Nature Immunology 6, 1207 - 1210 (2005)
doi:10.1038/ni1205-1207
Breaking down the barriers to cancer immunotherapyEllen Puré1, James P Allison2
& Robert D Schreiber31
Ellen Puré is with the Wistar Institute and The Ludwig Institute for Cancer, Philadelphia, Pennsylvania 19104, USA. 2
James P. Allison is with Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. 3
Robert D. Schreiber is with the Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Correspondence should be addressed to Ellen Puré pure@wistar.org Emerging insights into the mechanisms of activation and negative regulation of innate and adaptive immune cells are providing new opportunities for the development of safe and effective cancer vaccines.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
